BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19051424)

  • 41. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
    [No Abstract]   [Full Text] [Related]  

  • 42. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
    Fulop JA
    Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
    [No Abstract]   [Full Text] [Related]  

  • 43. Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS).
    American College Of Radiology
    J Am Coll Surg; 2007 Jul; 205(1):145-161. PubMed ID: 17617343
    [No Abstract]   [Full Text] [Related]  

  • 44. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
    Schmaltz J
    Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of in situ ductal breast cancer.
    Recht A
    Front Radiat Ther Oncol; 1993; 27():52-61. PubMed ID: 8389309
    [No Abstract]   [Full Text] [Related]  

  • 46. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
    Boyd DB
    Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
    [No Abstract]   [Full Text] [Related]  

  • 47. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Tunon de Lara C
    Gynecol Obstet Fertil; 2008 May; 36(5):499-506. PubMed ID: 18467151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Present problems and future prospects in breast cancer treatment].
    Kasumi F
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():167-74. PubMed ID: 17682153
    [No Abstract]   [Full Text] [Related]  

  • 49. International consensus conference. Image-detected breast cancer: state of the art diagnosis and treatment.
    International Breast Cancer Consensus Conference
    Breast J; 2002; 8(2):70-6. PubMed ID: 11896750
    [No Abstract]   [Full Text] [Related]  

  • 50. Ductal carcinoma in situ of the breast.
    Burstein HJ; Polyak K; Wong JS; Lester SC; Kaelin CM
    N Engl J Med; 2004 Apr; 350(14):1430-41. PubMed ID: 15070793
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of locally advanced breast cancer.
    Hortobagyi GN; Buzdar AU
    Am J Clin Oncol; 1988 Oct; 11(5):597-601. PubMed ID: 2845771
    [No Abstract]   [Full Text] [Related]  

  • 52. Standard for the management of ductal carcinoma in situ of the breast (DCIS).
    Morrow M; Strom EA; Bassett LW; Dershaw DD; Fowble B; Harris Ja; O'Malley F; Schnitt SJ; Singletary SE; Winchester DP; ; ; ;
    CA Cancer J Clin; 2002; 52(5):256-76. PubMed ID: 12363325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Not all ductal carcinoma in situ is created equal: can we avoid surgery for low-risk ductal carcinoma in situ?
    Lippey J; Spillane A; Saunders C
    ANZ J Surg; 2016 Nov; 86(11):859-860. PubMed ID: 27784140
    [No Abstract]   [Full Text] [Related]  

  • 54. Standard for breast conservation therapy in the management of invasive breast carcinoma.
    Morrow M; Strom EA; Bassett LW; Dershaw DD; Fowble B; Giuliano A; Harris JR; O'Malley F; Schnitt SJ; Singletary SE; Winchester DP; ; ; ;
    CA Cancer J Clin; 2002; 52(5):277-300. PubMed ID: 12363326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.
    Francis A; Fallowfield L; Rea D
    Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):6-8. PubMed ID: 25445552
    [No Abstract]   [Full Text] [Related]  

  • 57. Lumpectomy and chemotherapy. Unproved method of treating breast cancer.
    Pressman PI
    N Y State J Med; 1981 Nov; 81(12):1765-7. PubMed ID: 6276831
    [No Abstract]   [Full Text] [Related]  

  • 58. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
    Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
    Meijnen P; Gilhuijs KG; Rutgers EJ
    J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The shifting nature of women's experiences and perceptions of ductal carcinoma in situ.
    Kennedy F; Harcourt D; Rumsey N
    J Adv Nurs; 2012 Apr; 68(4):856-67. PubMed ID: 21790736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.